GHRSGH Research PLC

GHRS Stock Price, Valuation & Chart | GH Research PLC

Compare

$28.070+0.71 (+2.60%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology GHRS intrinsic value GHRS calculated fair value vs price

Overview Financials Dividends Ratios

GHRS Historical price chart

GHRS Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.92B

PE Ratio-28.07

EPS-1.0

Trading Volume111.83K

Today's High/Low28.25/27.09

Dividend Yield0.00

52 Week High/Low31.44/11.83

Shares Outstanding68.56M

GHRS Financial Statement

GHRS Analyst ratings

GHRS Analysis & performance metrics

GHRS Company profile

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company…

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product…

GHRS Management team

Name

Position

Julie Ryan F.C.A.

Vice President of Finance

Florian Schonharting M.Sc. (Econ)

Co-Founder & Non-Executive Chairman of the Board

Aaron Cameron M.B.A.COO

Chief Operating Officer

Magnus Halle

Co-Founder & MD of Ireland

Velichka Valcheva M.D., M.Sc.CEO

Chief Executive Officer

Name

Position

Julie Ryan F.C.A.

Vice President of Finance

Florian Schonharting M.Sc. (Econ)

Co-Founder & Non-Executive Chairman of the Board

Aaron Cameron M.B.A.COO

Chief Operating Officer

Magnus Halle

Co-Founder & MD of Ireland

Velichka Valcheva M.D., M.Sc.CEO

Chief Executive Officer

Management Team

Julie Ryan F.C.A.

Vice President of Finance

Florian Schonharting M.Sc. (Econ)

Co-Founder & Non-Executive Chairman of the Board

Aaron Cameron M.B.A.COO

Chief Operating Officer

Magnus Halle

Co-Founder & MD of Ireland

Velichka Valcheva M.D., M.Sc.CEO

Chief Executive Officer

Management

Julie Ryan F.C.A.

Vice President of Finance

Florian Schonharting M.Sc. (Econ)

Co-Founder & Non-Executive Chairman of the Board

Aaron Cameron M.B.A.COO

Chief Operating Officer

Magnus Halle

Co-Founder & MD of Ireland

Velichka Valcheva M.D., M.Sc.CEO

Chief Executive Officer

Total 5 executives

GHRS Frequently asked questions

What is GH Research PLC (GHRS) Stock Price?

Current stock price of GH Research PLC (GHRS) stock is $28.070. The stock price is +2.60% higher in the session. The intraday range can be seen from this page. Volume of GH Research PLC (GHRS) stock is 111.83K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the GH Research PLC (GHRS) stock price going up or down today?

The stock price of GH Research PLC (GHRS) can change with earnings, company news, and overall market sentiment. GH Research PLC operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the GH Research PLC stock expensive at its current price?

Whether GH Research PLC looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GHRS on this page is -28.07. EPS on this page is -1.00. Compare those figures with peers and growth expectations before deciding if the current GH Research PLC price is justified.

How has the stock price of GH Research PLC (GHRS) performed historically?

Historical performance for GH Research PLC (GHRS) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GHRS reacted to past earnings and market events.

Should I buy GH Research PLC (GHRS) stock, at this price?

Buying GH Research PLC (GHRS) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.